Journal of Shanghai Jiaotong University (Science)

Shanghai Jiaotong University Press
ISSN: 10071172, 19958188

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q2
SJR
0.227
CiteScore
1.8
Categories
Multidisciplinary
Areas
Multidisciplinary
Years of issue
2005-2025
journal names
Journal of Shanghai Jiaotong University (Science)
Publications
2 125
Citations
5 967
h-index
21
Top-3 citing journals
Ocean Engineering
Ocean Engineering (116 citations)
IEEE Access
IEEE Access (100 citations)
Top-3 organizations
Shanghai Jiao Tong University
Shanghai Jiao Tong University (1044 publications)
Shanghai University
Shanghai University (38 publications)
Tongji University
Tongji University (37 publications)
Top-3 countries
China (2053 publications)
USA (51 publications)
Japan (21 publications)

Most cited in 5 years

Found 
from chars
Publications found: 67162
ScreenDx, an artificial intelligence-based algorithm for the incidental detection of pulmonary fibrosis
Touloumes N., Gagianas G., Bradley J., Muelly M., Kalra A., Reicher J.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 0
Bronchobiliary Fistulas
Edmunds C., Hollingsworth J., Kouri B., Pawa R., Pawa S.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 0
Associations between psoriasis, psoriatic arthritis and gout or hyperuricemia: a systematic review and meta-analysis
Liu Z., Ma X., Chang T., Yao C., Song M., Biyue S., Zhang F., Liu J., Jiang Q.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 0
The utility of inpatient work-up of incidental anemia during hospitalization for an acute medical condition: a retrospective cohort study
Drozdinsky G., Halperin E., Kushnir S., Rudman Y., Gafter-Gvili A.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 0
Impact of non-genetic factors on severe cutaneous adverse reactions and associated mortality in ESRD patients: Advancing clinical guidance
Smaha K.M., Talebi N.N., Waller J.L., Baer S.L., Bollag W.B.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 0
Epidemiology and Prognosis of Sepsis in Cancer Patients: A Multicenter Prospective Observational Study
Ture Z., İskender G., Serhat Şahinoğlu M.M., Beste Özkara M.E., Kalem A.K., Eren E.E., Yekta Ürkmez F., Çetin S., Azak E., Erdem İ., Rello J., Alp E.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 0
The “Fixed Period,” the Wildfire News, and an Unpublished Manuscript: Osler's Farewell Speech Revisited in Geographical Breadth and Emotional Depth
Anderson M., Scofield R.H.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 0
The effect of Empagliflozin on alleviating C4d over-activation in Diabetic kidney disease
Fayed A., Fathy A., Rakha N.K., Soliman K.M., Hammad H.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 0
Facial Metastasis of Esophageal Squamous Cell Carcinoma
Shai S., Kuo H., Lai Y., Hsieh C.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 0
Combined Pulmonary Fibrosis and Emphysema: From Radiology to Reality – Rethinking Progression and Prognosis
Santibanez V.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 0
Noninvasive Ventilation for Respiratory Failure: When does it work and when it does not?
Gong Y., Ponnapalli A., Hafeez K., Soubani A.O.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 0
Single nucleotide polymorphisms of GEMIN3 modify the risk of primary Sjögren's syndrome in female patients
Wang D., Zhang J., Zhao Y., Cao R., Wang Y., Guo I., Peng C., Song Y., Zhang S.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 0  |  Abstract
MicroRNA (miRNA)-processing machinery may modify the risk of primary Sjögren's syndrome (pSS) by altering miRNA expression profiles. Inflammatory cytokines and reactive oxygen species (ROS) are also involved in pSS; however, the role of altered miRNAs expression in its pathogenesis is still unclear. We aimed to evaluate the relationship between single-nucleotide polymorphisms (SNPs) in miRNA processing machinery genes, including XPO5 (rs11077), RAN (rs14035), Dicer (rs3742330), TNRC6B (rs9623117), GEMIN3 (rs197412), and GEMIN4 (rs2740348), and the risk of pSS in female patients. The potential associations of cytokines and ROS with pSS-susceptible SNPs were also evaluated.
Kartagener's Syndrome
Zeng Y., Peng G., He J., Yang C., Xu X.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 0  |  Abstract
A 36-year-old man presented to a respiratory medicine clinic for evaluation of a cough and yellow, purulent sputum for > 20 years. The cough had worsened since asthma was diagnosed 3 months prior. He had a history of chronic sinusitis. The physical examination showed that the heart was within the right thorax. A chest radiograph showed increased lung texture with multiple cystic translucencies in both lungs (Figure 1, white arrow) and transposition of the heart (Panel A, blue arrow). Computed tomography (CT) of the chest revealed bronchiectasis (Panel B, white arrow) and a right-sided heart (Panel B, blue arrow). An abdominal color ultrasound showed that the liver was situated on the left and the spleen was situated on the right. In addition, CT of the head showed mucosal thickening (Panel C, white arrow) and a low-density shadow filling the paranasal sinuses (Panel C, blue arrow). Kartagener's syndrome is a hereditary disease with the following typical symptoms: situs inversus; bronchiectasis; and chronic infections of the nasal mucosa. Bronchiectasis and recurrent lung infections can develop into end-stage lung diseases. The patient underwent a double lung transplant and was discharged in stable condition 1 month postoperatively. The patient was doing well at the 5-year follow-up evaluation. Panel D shows the most recent chest CT scan.
Systematically investigate the mechanism underlying the therapeutic effect of Astragalus membranaceus in ulcerative colitis
Mao J., Tan L., Tian C., Wang W., Zou Y., Zhu Z., Li Y.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 2  |  Abstract
Whether Astragalus membranaceus is an effective drug in treatment of ulcerative colitis (UC) and how it exhibit activity effect on UC is unclear.
Mixed glandular neuroendocrine carcinoma of the endometrium with hypercalcemic crisis
Luo M., Yu X., Chen Z., Li Z.
Q2
Elsevier
American Journal of the Medical Sciences 2025 citations by CoLab: 0  |  Abstract
To explore the ideas and research progress in diagnosing and treating hypercalcemic crisis in patients with cancer.

Top-100

Citing journals

20
40
60
80
100
120
140
Show all (70 more)
20
40
60
80
100
120
140

Citing publishers

200
400
600
800
1000
1200
1400
Show all (70 more)
200
400
600
800
1000
1200
1400

Publishing organizations

200
400
600
800
1000
1200
Show all (70 more)
200
400
600
800
1000
1200

Publishing organizations in 5 years

50
100
150
200
250
300
Show all (70 more)
50
100
150
200
250
300

Publishing countries

500
1000
1500
2000
2500
China, 2053, 96.61%
USA, 51, 2.4%
Japan, 21, 0.99%
India, 20, 0.94%
United Kingdom, 16, 0.75%
Australia, 9, 0.42%
Netherlands, 6, 0.28%
Singapore, 5, 0.24%
Germany, 4, 0.19%
France, 4, 0.19%
Egypt, 4, 0.19%
Canada, 4, 0.19%
Pakistan, 4, 0.19%
Republic of Korea, 4, 0.19%
Portugal, 2, 0.09%
Italy, 2, 0.09%
Poland, 2, 0.09%
Slovenia, 2, 0.09%
Switzerland, 2, 0.09%
Russia, 1, 0.05%
Vietnam, 1, 0.05%
Denmark, 1, 0.05%
Malaysia, 1, 0.05%
Nigeria, 1, 0.05%
Norway, 1, 0.05%
Saudi Arabia, 1, 0.05%
Thailand, 1, 0.05%
Uganda, 1, 0.05%
Finland, 1, 0.05%
Sweden, 1, 0.05%
500
1000
1500
2000
2500

Publishing countries in 5 years

100
200
300
400
500
600
700
China, 603, 92.48%
India, 14, 2.15%
USA, 11, 1.69%
Egypt, 4, 0.61%
United Kingdom, 3, 0.46%
Japan, 3, 0.46%
Canada, 2, 0.31%
Russia, 1, 0.15%
Australia, 1, 0.15%
Denmark, 1, 0.15%
Malaysia, 1, 0.15%
Nigeria, 1, 0.15%
Norway, 1, 0.15%
Pakistan, 1, 0.15%
Republic of Korea, 1, 0.15%
Saudi Arabia, 1, 0.15%
Uganda, 1, 0.15%
Switzerland, 1, 0.15%
100
200
300
400
500
600
700